ELIAS Animal Health
Olathe
About ELIAS Animal Health
ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Their approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. ELIAS Cancer Immunotherapy (ECI™) harnesses the power of the dog’s own immune system to eliminate the cancer. ECI™ utilizes adoptive cell therapy to deliver an army of activated T cells that kill cancer cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2024)
- Website: eliasanimalhealth.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elias-animal-health-65974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.